PubRank

Cindy S-Y Lin

Author PubWeight™ 49.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Botulinum toxin modulates cortical maladaptation in post-stroke spasticity. Muscle Nerve 2013 2.00
2 Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005 1.86
3 Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain 2009 1.50
4 Changes in human sensory axonal excitability induced by an ischaemic insult. Clin Neurophysiol 2008 1.49
5 Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy. Clin Neurophysiol 2010 1.41
6 Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 2009 1.37
7 Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 2014 1.36
8 Axonal ion channels from bench to bedside: a translational neuroscience perspective. Prog Neurobiol 2009 1.27
9 Motoneuron excitability and the F wave. Muscle Nerve 2003 1.18
10 Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy. Brain 2008 1.10
11 Differences in activity-dependent hyperpolarization in human sensory and motor axons. J Physiol 2004 1.06
12 Changes in human sensory axonal excitability induced by focal nerve compression. J Physiol 2010 1.04
13 Impact of oxaliplatin-induced neuropathy: a patient perspective. Support Care Cancer 2012 0.98
14 Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann Neurol 2002 0.96
15 Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PLoS One 2011 0.92
16 Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve 2010 0.88
17 Assessment of nerve excitability in toxic and metabolic neuropathies. J Peripher Nerv Syst 2008 0.88
18 Puffer fish poisoning: a potentially life-threatening condition. Med J Aust 2002 0.88
19 Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes 2012 0.87
20 Excitability changes in human peripheral nerve axons in a paradigm mimicking paired-pulse transcranial magnetic stimulation. J Physiol 2002 0.86
21 Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Brain 2005 0.85
22 Effects of hemodiafiltration and high flux hemodialysis on nerve excitability in end-stage kidney disease. PLoS One 2013 0.85
23 Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy. Brain 2011 0.84
24 Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis. J Neurol 2015 0.84
25 Motor cortex excitability in acute cerebellar infarct. Cerebellum 2013 0.83
26 Ischaemic sensitivity of axons in carpal tunnel syndrome. J Peripher Nerv Syst 2009 0.83
27 Effects of voluntary activity on the excitability of motor axons in the peroneal nerve. Muscle Nerve 2002 0.83
28 Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy. Brain 2002 0.83
29 Activity-dependent conduction failure: molecular insights. J Peripher Nerv Syst 2011 0.82
30 Nerve excitability properties in lower-limb motor axons: evidence for a length-dependent gradient. Muscle Nerve 2004 0.81
31 Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity. Oncology 2009 0.81
32 Nerve excitability assessment in chemotherapy-induced neurotoxicity. J Vis Exp 2012 0.80
33 Longitudinal plasticity across the neural axis in acute stroke. Neurorehabil Neural Repair 2012 0.80
34 Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy. Exp Neurol 2010 0.80
35 Axonal dysfunction prior to neuropathy onset in type 1 diabetes. Diabetes Metab Res Rev 2013 0.80
36 Excitability differences in lower-limb motor axons during and after ischemia. Muscle Nerve 2005 0.80
37 Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes. Diabetes Care 2013 0.79
38 Nerve compression, membrane excitability, and symptoms of carpal tunnel syndrome. Muscle Nerve 2011 0.79
39 Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability. J Physiol 2012 0.79
40 Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment? J Clin Oncol 2011 0.78
41 Acute, reversible axonal energy failure during stroke-like episodes in MELAS. Pediatrics 2010 0.78
42 The effects of large artery ischemia and subsequent recanalization on nerve excitability. Muscle Nerve 2011 0.78
43 Adaptation of motor function after spinal cord injury: novel insights into spinal shock. Brain 2010 0.77
44 Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies. Muscle Nerve 2014 0.77
45 Activity-dependent hyperpolarization and impulse conduction in motor axons in patients with carpal tunnel syndrome. Brain 2003 0.76
46 Impaired energy-dependent processes underlie acute lead neuropathy. Muscle Nerve 2012 0.76
47 Transynaptic changes evident in peripheral axonal function after acute cerebellar infarct. Cerebellum 2014 0.76
48 Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy. Muscle Nerve 2002 0.76
49 Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus. Diabetes Metab Res Rev 2014 0.76
50 Excitability properties of human median axons measured at the motor point. Muscle Nerve 2004 0.76
51 Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes. BMC Cancer 2014 0.76
52 The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects? Cancer Chemother Pharmacol 2011 0.75
53 Burning pain: axonal dysfunction in erythromelalgia. Pain 2017 0.75
54 Conduction and excitability properties of peripheral nerves in end-stage liver disease. Muscle Nerve 2007 0.75